platinum has been researched along with arginyl-glycyl-aspartic acid in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
De Giglio, E; Sabbatini, L; Zambonin, PG | 1 |
Barnés, CM; Barnes, KR; Haskel, A; Lippard, SJ; Mukhopadhyay, S; Short, SM | 1 |
Chen, Y; Liu, B; Tang, BZ; Yuan, Y | 1 |
Gai, S; Gu, R; Gulzar, A; He, F; Lv, R; Yang, G; Yang, P; Zhang, S; Zhong, C | 1 |
Cheng, Y; Wang, Y; Yan, Y; Zhang, Q; Zhou, Z | 1 |
Chatzisideri, T; Dalezis, P; Gederaas, OA; Katsamakas, S; Lazarides, T; Lindgren, M; Nikolakaki, E; Sarli, V; Sigala, I; Thysiadis, S; Trafalis, D | 1 |
Chen, Y; Han, R; Hao, Y; He, X; Liu, Q; Liu, T; Qian, Z; Yang, C; Yang, Y | 1 |
7 other study(ies) available for platinum and arginyl-glycyl-aspartic acid
Article | Year |
---|---|
Development and analytical characterization of cysteine-grafted polypyrrole films electrosynthesized on Pt- and Ti-substrates as precursors of bioactive interfaces.
Topics: Amino Acid Sequence; Animals; Cell Adhesion; Cells, Cultured; Coated Materials, Biocompatible; Cysteine; Electrochemistry; Oligopeptides; Peptides; Platinum; Polymers; Protein Binding; Pyrroles; Rats; Spectrometry, X-Ray Emission; Surface Properties; Titanium | 1999 |
Conjugated platinum(IV)-peptide complexes for targeting angiogenic tumor vasculature.
Topics: Amino Acid Motifs; Animals; Cattle; CD13 Antigens; Cell Line, Tumor; Cell Proliferation; Cisplatin; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Inhibitory Concentration 50; Integrin alphaV; Neoplasms; Neovascularization, Pathologic; Oligopeptides; Organometallic Compounds; Peptides; Platinum | 2008 |
A targeted theranostic platinum(IV) prodrug containing a luminogen with aggregation-induced emission (AIE) characteristics for in situ monitoring of drug activation.
Topics: Cell Line, Tumor; Cell Survival; Coordination Complexes; Fluorescent Dyes; Humans; MCF-7 Cells; Microscopy, Confocal; Oligopeptides; Platinum; Prodrugs; Pyridines | 2014 |
Synthesis, luminescence, and anti-tumor properties of MgSiO3:Eu-DOX-DPP-RGD hollow microspheres.
Topics: Animals; Antineoplastic Agents; Cell Survival; Doxorubicin; Drug Carriers; Endocytosis; Erythrocytes; Europium; HeLa Cells; Hemolysis; Humans; Light; Mice; Microspheres; Neoplasms; Oligopeptides; Platinum; Porosity; Prodrugs; Silicon Dioxide; Transplantation, Heterologous | 2015 |
Dendrimer-Templated Ultrasmall and Multifunctional Photothermal Agents for Efficient Tumor Ablation.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Copper; Dendrimers; Fluorescent Dyes; Humans; Light; Male; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Oligopeptides; Optical Imaging; Palladium; Particle Size; Peptide Fragments; Photosensitizing Agents; Phototherapy; Platinum; Surface Properties | 2016 |
Synthesis and biological evaluation of a Platinum(II)-c(RGDyK) conjugate for integrin-targeted photodynamic therapy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Integrins; Molecular Structure; Oligopeptides; Organoplatinum Compounds; Photochemotherapy; Platinum; Rats; Structure-Activity Relationship | 2017 |
RGD peptide modified platinum nanozyme Co-loaded glutathione-responsive prodrug nanoparticles for enhanced chemo-photodynamic bladder cancer therapy.
Topics: Cell Line, Tumor; Glutathione; Humans; Nanoparticles; Oligopeptides; Paclitaxel; Photochemotherapy; Photosensitizing Agents; Platinum; Polyethylene Glycols; Prodrugs; Tumor Microenvironment; Urinary Bladder Neoplasms | 2023 |